Development of AAV-Based CRISPR/Cas9 Therapies for Correcting Duchenne Muscular Dystrophy by Targeted Genomic Integration
Publication
, Conference
Pickar-Oliver, A; Nelson, C; Bohning, J; Gemberling, M; Bulaklak, K; Gersbach, CA
Published in: MOLECULAR THERAPY
April 22, 2019
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 22, 2019
Volume
27
Issue
4
Start / End Page
180 / 181
Location
Washington, DC
Publisher
CELL PRESS
Conference Name
22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Pickar-Oliver, A., Nelson, C., Bohning, J., Gemberling, M., Bulaklak, K., & Gersbach, C. A. (2019). Development of AAV-Based CRISPR/Cas9 Therapies for Correcting Duchenne Muscular Dystrophy by Targeted Genomic Integration. In MOLECULAR THERAPY (Vol. 27, pp. 180–181). Washington, DC: CELL PRESS.
Pickar-Oliver, Adrian, Christopher Nelson, Joel Bohning, Matthew Gemberling, Karen Bulaklak, and Charles A. Gersbach. “Development of AAV-Based CRISPR/Cas9 Therapies for Correcting Duchenne Muscular Dystrophy by Targeted Genomic Integration.” In MOLECULAR THERAPY, 27:180–81. CELL PRESS, 2019.
Pickar-Oliver A, Nelson C, Bohning J, Gemberling M, Bulaklak K, Gersbach CA. Development of AAV-Based CRISPR/Cas9 Therapies for Correcting Duchenne Muscular Dystrophy by Targeted Genomic Integration. In: MOLECULAR THERAPY. CELL PRESS; 2019. p. 180–1.
Pickar-Oliver, Adrian, et al. “Development of AAV-Based CRISPR/Cas9 Therapies for Correcting Duchenne Muscular Dystrophy by Targeted Genomic Integration.” MOLECULAR THERAPY, vol. 27, no. 4, CELL PRESS, 2019, pp. 180–81.
Pickar-Oliver A, Nelson C, Bohning J, Gemberling M, Bulaklak K, Gersbach CA. Development of AAV-Based CRISPR/Cas9 Therapies for Correcting Duchenne Muscular Dystrophy by Targeted Genomic Integration. MOLECULAR THERAPY. CELL PRESS; 2019. p. 180–181.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 22, 2019
Volume
27
Issue
4
Start / End Page
180 / 181
Location
Washington, DC
Publisher
CELL PRESS
Conference Name
22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences